In COVID-19, the immune response is characterized by high plasma levels of interleukins (IL-6, IL-2), interferons (IFN-y,) chemokines (CXCL10, CCL2, CCL3), growth factors (granulocyte colony stimulating factor) and tumor necrosis factor (TNFα). This evidence concerns the gene IL6 and COVID-19.